Evidence map›Paper›PMID 40002205›Full record

ArticleCancers2025

IER5 Promotes Ovarian Cancer Cell Proliferation and Peritoneal Dissemination.

Jayaraman Krishnaraj, Sayaka Ueno, Moe Nakamura, Yuko Tabata, Tatsuki Yamamoto, Yoshinori Asano, Tomoaki Tanaka, Tomohisa Kuzuyama, Hideyuki Saya, Rieko Ohki

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jayaraman KrishnarajLaboratory of Fundamental Oncology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.ORCID 0000-0002-0116-0546
Sayaka UenoDepartment of Genomic Medicine, Fujita Health University, Toyoake 470-1192, Japan.ORCID 0000-0003-1138-5631
Moe NakamuraLaboratory of Fundamental Oncology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Yuko TabataLaboratory of Fundamental Oncology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Tatsuki YamamotoLaboratory of Fundamental Oncology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Yoshinori AsanoLaboratory of Fundamental Oncology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Tomoaki TanakaDepartment of Molecular Diagnosis, Chiba University School of Medicine, Chiba 260-0856, Japan.ORCID 0000-0002-9761-1750
Tomohisa KuzuyamaGraduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8654, Japan.ORCID 0000-0002-7221-5858
Hideyuki SayaDepartment of Genomic Medicine, Fujita Health University, Toyoake 470-1192, Japan.ORCID 0000-0001-6610-1902
Rieko OhkiLaboratory of Fundamental Oncology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.ORCID 0000-0002-7775-6653

Funding

Japan Agency for Medical Research and Development P-Direct and P-CreateMinistry of Education, Culture, Sports, Science and Technology #20H03523, #20K07605
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HSF1HSPIER5metastasisovarian cancer

Identifiers

PMID40002205
PMCPMC11853144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.